Initial analysis from an international clinical trial has indicated that the investigational drugs didn’t slow memory loss, cognitive decline in rare, inherited Alzheimer’s. The clinical trial evaluating whether two investigational
Nordic Life Science
NLS News
Initial analysis from an international clinical trial has indicated that the investigational drugs didn’t slow memory loss, cognitive decline in rare, inherited Alzheimer’s. The clinical trial evaluating whether two investigational
Xbrane Biopharma strengthens its management team to better equip the company for commercialization of its biosimilars and Paolo Sarmientos steps out of the management team. Xbrane Biopharma is advancing its
Olli Pietiläinen has been appointed as a group leader to the Neuroscience Center (NC) in Helsinki. Pietiläinen received his PhD in Molecular Genetics from the University of Helsinki, while also
Through the Directed Share Issue, Cantargia will receive proceeds amounting to approximately SEK 410 million before transaction related costs. Investors in the Directed Share Issue are a wide range of
AstraZeneca’s BioVentureHub has entered into a new collaboration with IBM Sweden. The collaboration gives small and mid-sized companies connected to IBM Sweden or AstraZeneca’s BioVentureHub access to each others’ open
15 million SEK has been invested in MediTuners’s digital asthma-app. Almi Invest is investing 3 million SEK in MediTuner and its app AsthmaTuner, developed together with Karolinska Institutet. The app
Photocure has announced that the United States Patent and Trademark Office (USPTO) has granted US Patent covering the use of Blue Light Cystoscopy (BLC) with Hexvix as neoadjuvant therapy in
AroCell has announced that the patent titled “Monoclonal anti-TK1 antibodies” is granted by China National Intellectual Property Administration (CNIPA). The patent relates to AroCell’s monoclonal antibodies used for determining the
Profile
Barbro Ehnbom has successfully promoted women in their careers, not least within life sciences, and she is herself a living example of the changes she has pushed for.
Drug and device development
The combined Nordic population is 27 million – an impressive cohort for health studies. Last spring, a delegation visited Washington, D.C. to promote Nordic registries and biobanks for precision medicine
Initial analysis from an international clinical trial has indicated that the investigational drugs didn’t slow memory loss, cognitive decline in rare, inherited Alzheimer’s. The clinical trial evaluating whether two investigational
InDex Pharmaceuticals has announced the conclusions from in-depth analysis of the complete data set from the phase IIb dose optimisation study CONDUCT, evaluating the first-in-class TLR9 agonist cobitolimod for the
Scandinavian Biopharma has been awarded a 10.6 million EUR grant from EDCTP in international competition for the planned Phase III clinical trial of the ETEC vaccine candidate ETVAX. The EDCTP
Ascelia Pharma has announced that the first patient has been enrolled in the company’s global Phase III clinical study SPARKLE with Mangoral in patients with severely reduced renal function and
Financing
Eugen Steiner has worked in venture capital for 23 years but his roots as a medical doctor still influence the way he nurtures start-ups as a venture partner.
Petri Laine is Managing Partner at Innovestor Ventures, a venture capital arm of Innovestor Group. He has been working with high-growth companies for 20 years and prior to joining Innovestor he
Ingrid Teigland Akay is Managing Partner at Hadean Ventures, a life science fund manager that invests in life science companies across Europe, with a particular focus on the Nordic region.
“It was basically a door that opened. In academia it would take ten or more years to have your own lab, but here I was being invited to do just that.”
EUGEN STEINER, HEALTHCAP
The Nobel Prize
Professor Honjo did not set out to find a cure for cancer but he is glad he did not give up and believes cancer immunotherapy will be the Number One
When your passion and lifelong work are the same. Great things can happen. Just ask James Allison.
The 2018 Nobel Prize in Medicine was awarded to James P. Allison and Tasuku Honjo for ther pioneering work in cancer immunotheraphy.
“Immunotherapy can be combined with almost anything; you can combine it with chemotherapy or radiation as long as you do it right. The benefits of immunotherapy are several; the best one is that once T cells see something different about the cancer cell and attack the cancer, they can be re-activated [if the cancer reoccurs.]” – James Allison
Upcoming events
Nordic Precision Medicine Forum returns to Stockholm alongside a new co-located forum – Nordic AI in Healthcare and Medicine. The Nordic countries continue to grab the headlines as an incubator
Focusing on development and manufacturing of high quality biologic drugs and vaccines. This is a biologic drugs and vaccines conference in the Nordic region that will bring together the Nordic
The fourteenth annual BIO-Europe Spring conference is the premier springtime partnering conference for the biotechnology industry. For its 2020 edition, BIO-Europe Spring returns to Paris, France on March 23–25, 2020. Theconference annually attracts the
BioTrinity is a two day life sciences conference that takes place in Central London. BioTrinity focuses on partnering, investment and collaboration and aims to inspire growth and create opportunities for all who
In a new job
Helena Strigård, M.Sc. Molecular Biotechnology and BA Business Economy, has previously worked as an advisor within research and innovation politics at the Confederation of Swedish Enterprise and as an advisor
The Board of Directors of Immunicum has announced that, by mutual agreement, Carlos de Sousa has resigned as CEO of Immunicum effective immediately. The Board has appointed Alex Karlsson-Parra, Immunicum’s
BioArctic will be strengthening its management team in 2020 through two strategic recruitments. As of January 1, Tomas Odergren will assume the role of Chief Medical Officer and as of
Careers
Ann-Britt Önnered and Linda Jervelius manage Quality Assurance at a microbiology laboratory and share their insights about maintaining a secure and hygienic laboratory environment, a crucial part of lab life.
New issue of NLS is out now!
ISSUE 04 2019 // This issue features an exclusive interview with business woman Barbro Ehnbom, within life sciences perhaps best known as the founder of SALSS. This issue also contains a mini-theme on Drug development. We also reveal new Nordic findings from CryoEM data and we have spoken to Ed Boyden, the winner of the Lennart Nilsson Award.
Our region is filled with life science activity. We take a closer look at what´s going in our Nordic cities when it comes to life science efforts, progress and challenges.
In focus – Nordic cities
Nordic Life Science
The latest clinical trials
Initial analysis from an international clinical trial has indicated that the investigational drugs didn’t slow memory loss, cognitive decline in rare, inherited Alzheimer’s. The clinical trial evaluating whether two investigational
InDex Pharmaceuticals has announced the conclusions from in-depth analysis of the complete data set from the phase IIb dose optimisation study CONDUCT, evaluating the first-in-class TLR9 agonist cobitolimod for the
Scandinavian Biopharma has been awarded a 10.6 million EUR grant from EDCTP in international competition for the planned Phase III clinical trial of the ETEC vaccine candidate ETVAX. The EDCTP
Ascelia Pharma has announced that the first patient has been enrolled in the company’s global Phase III clinical study SPARKLE with Mangoral in patients with severely reduced renal function and
Elypta has enrolled the first patient in the multi-center AURORAX-087A (AUR87A) study involving its novel liquid biopsy platform. This was achieved at the department of Urology, Norfolk and Norwich University
Immunicum has announced updated results from the randomized Phase II MERECA trial testing its off-the-shelf immune primer ilixadencel in combination with Sutent (sunitinib) first-line treatment regimen in newly diagnosed metastatic
Follicum has received approval from the German Medicines Agency (BfArM) and the German Ethics Committee to start a Phase IIa clinical study with a topical formulation of FOL-005 on patients
Targovax has announced the first set of clinical results from the randomized phase I/II trial of ONCOS-102 in combination with standard of care chemotherapy in malignant pleural mesothelioma (MPM). The
The AstraZeneca trial met primary endpoint of objective response rate and key secondary endpoint of overall survival in patients with previously treated HER2-positive metastatic gastric cancer. Results from the positive
The latest research news from the Nordic region
Science Article
Professor Ed Boyden has won the Lennart Nilsson Award 2019 for developing a new technique called expansion microscopy. But his research expands beyond this discovery, for example into the exciting
A common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia (AML), one of the most common forms of blood cancer. This is
Researchers at Karolinska Institutet and Tampere University have developed a method based on artificial intelligence (AI) for histopathological diagnosis and grading of prostate cancer. The AI-system has the potential to
Scientists at SciLifeLab have provided medical research with a detailed description of the proteins in human blood. Published in the journal Science, the Blood Atlas resource is the latest database
As weather warms, heart attack risks may decline, says a Lund University study. Heart attacks seem more common in winter, doctors have long observed, including in a nearly 100-year-old clinical
A new scientific study showing how fish behavior is being changed by pharmaceuticals entering water habitats after being incorrectly disposed highlights the urgent need for research into the impact of
Sign up to our newsletter